Jamie Cate and fellow UC Berkeley researchers have now found a promising new drug target within that pathway that is appealing, in part, because it appears to control production of only a few percent of the body’s many proteins, those critical to regulating the growth and proliferation of cells...Read more about When targeting cancer genes, zero in on the 1 percent
To help cancer drugs access tumors, Ting Xu and collaborators are making tiny particles called nanocarriers that protect the drugs during their journey to the tumor. Read the article.Read more about Finding Chemo
Taiwan's top science award, the Tang Prize, has gone to two UC Berkeley scientists well-known in the fields of biochemistry and physics: Jennifer Doudna, for her invention of CRISPR-Cas9 gene editing, and Arthur Rosenfeld, often called the "godfather of energy efficiency."
Bernardo Gouveia of Berkeley Engineers and Mentors (BEAM) discusses BEAM's recent Zipcar 2016 “Students with Drive” award.Read more about BEAM wins Zipcar award
Controlled self-assembly of proteins is being exploited in the emerging field of protein nanotechnology to create nanoscale structures. Simple protein subunits assembled into complex designs give rise to functional materials and devices.
